Sponsor Pipeline

Telios Pharma, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06225973
A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease		 overall status: Active, Not Recruiting → Unknown
Active Trials by Phase
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06686472 Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis Allergic Conjunctivitis Recruiting
NCT07220408 Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis Allergic Conjunctivitis Recruiting
Phase 1/2
NCT05280509 Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and… Myelofibrosis Recruiting
Disease Areas
Myelofibrosis (1)
Get alerts when Telios Pharma, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free